# 📝 DermaScan AI: Project Progress Log

This document serves as a persistent, append-only log to track project phases, agentic actions, major architectural decisions, and research outcomes.

---

### [2026-08-21] Phase 1: Project Status Analysis
- **Action:** Analyzed the entire `DermaScan-AI-All-versions` repository.
- **Findings:** Identified V4 as the latest architecture (Next.js + FastAPI) and V3 as the stable Streamlit baseline. Noted the current model accuracy of 67.75%.
- **Output:** Generated `project_status_report.md`.

### [2026-08-21] Phase 2: Vulnerability & Bias Research
- **Action:** Deployed 5 simulated sub-agents to research diverse skin-tone datasets (focusing on Indian demographics). Deployed another 5 to identify critical flaws in the current model.
- **Findings:** 
  - Identified **DermaCon-IN** and **DDI** as the best datasets for resolving skin-tone bias.
  - Pinpointed 5 major limitations: Skin Tone Bias, Low Melanoma Sensitivity (48%), Low Overall Accuracy, OOD Failure (Cancer-only focus), and Rigid Metadata Dependency.
- **Output:** Generated `comprehensive_research_report.md`.

### [2026-08-21] Phase 3: Solution Exploration & Resolution
- **Action:** Deployed 10 simulated sub-agents (2 researchers per limitation) to debate and conclude on the best modern Deep Learning solutions for the identified flaws.
- **Decisions Made:**
  1. **Bias:** Hybrid approach (GenAI augmentation + Adversarial Domain Adaptation).
  2. **Sensitivity:** Implement Focal Loss + MixUp Augmentation.
  3. **Accuracy:** Add Soft Attention blocks + Multi-Resolution training.
  4. **OOD Detection:** Implement a Multi-Task BinaryHead for "Unknown" disease flagging.
  5. **Metadata:** Adopt an Imputation-Free Architecture (Modality-Dropout) for robust fallbacks.
- **Output:** Generated `solutions_to_limitations.md`.

### [2026-08-21] Phase 4: Implementation Planning & Validation
- **Action:** Simulated a "Validator Agent" to critique the initial implementation strategy. 
- **Validator Critique:** Noted that modifying the legacy V3 `model.py` directly is unsafe. Recommended decoupling the new training pipeline into the V4 backend. Emphasized incremental architectural upgrades to prevent catastrophic forgetting.
- **Decisions Made:** Drafted a comprehensive implementation plan to build a new training pipeline. 

### [2026-08-21] Phase 5: V5 Standalone Architecture Planning
- **Action:** User provided feedback. Shifted strategy from integrating into V4 to building a completely standalone `/v5/` directory. Target compute shifted to local laptop.
- **Decisions Made:** Established requirements checklist (Missing full datasets, required laptop-optimized training loop) and defined the linear pipeline: Data -> Model -> Test -> Report -> UI.
- **Output:** Updated `implementation_plan.md`.

### [2026-08-21] Phase 6: Clinical Output Refinement
- **Action:** User requested a paradigm shift from a Computer Science output (Binary Cancer vs Non-Cancer) to a Clinical Dermatologist output.
- **Decisions Made:** Swapped the Binary OOD head for an **Etiology Category Head** (Melanocytic, Keratinocytic, Inflammatory, Vascular). The primary head will now output a **Top 3 Differential Diagnosis (DDx)**. A post-processing script will convert probabilities into a **Malignancy Risk Index** to provide actionable clinical recommendations.
- **Output:** Finalized `implementation_plan.md` for user approval.

---
*End of Log*
